Transform Your Pharma Company with Digital Continuity
Download the white paper to learn more about IDMP requirements, and how a platform can support digital continuity across the lifecycle of a product.
IDMP compliance requires that the information sent to regulatory agencies be consistent in format and ISO coding. Dassault Systèmes believes that IDMP offers a significant opportunity beyond compliance:- digital continuity can provide a competitive advantage to your pharmaceutical organization.
Read our new white paper to gain powerful insights, such as:
- Digital continuity – what is it and what transformation means for biopharma companies
- Turning IDMP challenges into significant opportunities and competitive advantage
- Why Dassault Systèmes’ unique approach to digital continuity can support your organization’s business needs and create real value.
License to Cure for BioPharma is an Industry Solution Experience available from the apps represented on the 3DEXPERIENCE platform: BIOVIA.
IDMP: An Opportunity for Digital Continuity in the Pharmaceutical Industry